Refractory cytopenia with multilineage dysplasia

Refractory cytopenia with multilineage dysplasia
Classification and external resources
ICD-O	MM9985/3

Refractory cytopenia with multilineage dysplasia is a form of myelodysplastic syndrome.^[1]

It is abbreviated "RCMD".^[2]^[3]

References

Myeloid hematological malignancy/leukemia histology (ICD-O 9590–9989, C81–C96, 200–208)

AML:	Acute myeloblastic leukemia M0 M1 M2 APL/M3

MP	Chronic neutrophilic leukemia

AML	AMoL/M5 Myeloid dendritic cell leukemia

CML	Philadelphia chromosome Accelerated phase chronic myelogenous leukemia

AML	M4

MD-MP	Juvenile myelomonocytic leukemia Chronic myelomonocytic leukemia

Other

AML	Acute basophilic

AML	Acute eosinophilic

MP	Chronic eosinophilic leukemia/Hypereosinophilic syndrome

AML	Erythroleukemia/M6

MP	Polycythemia vera

MD	Refractory anemia Refractory anemia with excess of blasts Chromosome 5q deletion syndrome Sideroblastic anemia Paroxysmal nocturnal hemoglobinuria Refractory cytopenia with multilineage dysplasia

Mastocytoma	Mast cell leukemia Mast cell sarcoma Systemic mastocytosis

Mastocytosis:	Diffuse cutaneous mastocytosis Erythrodermic mastocytosis Adult type of generalized eruption of cutaneous mastocytosis Urticaria pigmentosa Mast cell sarcoma Solitary mastocytoma

Systemic mastocytosis	Xanthelasmoidal mastocytosis

Multiple/unknown

AML	Acute panmyelosis with myelofibrosis Myeloid sarcoma

MP	Myelofibrosis Acute biphenotypic leukaemia

Index of cells from bone marrow

Description	Immune system Cells Physiology coagulation proteins granule contents colony-stimulating heme and porphyrin metabolism intermediates

Disease	Red blood cell Monocyte and granulocyte Neoplasms and cancer Histiocytosis Symptoms and signs eponymous Blood tests findings

Treatment	Transfusion Drugs thrombosis bleeding other

↑ Rosati S, Mick R, Xu F et al. (January 1996). "Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome". Leukemia 10 (1): 20–6. PMID 8558932.
↑ Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (January 2009). "Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden". Biol. Blood Marrow Transplant. 15 (1): 30–8. doi:10.1016/j.bbmt.2008.10.012. PMID 19135940.
↑ Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H (November 2008). "Clinical significance of regulatory T cells in patients with myelodysplastic syndrome". Eur. J. Haematol. 82 (3): 201–7. doi:10.1111/j.1600-0609.2008.01182.x. PMID 19018862.